Lofexidine Oral Tablet [Lucemyra]
RxNorm 2046594
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2046594 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lofexidine Oral Tablet [Lucemyra].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Lofexidine Oral Tablet [Lucemyra]
(Atom ID: 10274882)
Patient Education
Lofexidine
Lofexidine is used to manage opioid withdrawal symptoms (e.g., sick feeling, stomach cramps, muscle spasms or twitching, cold sensation, heart pounding, muscle tension, aches and pains, yawning, runny eyes, or difficulty falling asleep or staying asleep) that may occur after an opioid medication is suddenly stopped. Lofexidine is in a class of medications called central alpha adrenergic agonists. It works by relaxing blood vessels so that blood can flow more easily through the body.
[Learn More]
* Please review the disclaimer below.